CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Revolution Medicines Inc 's Leverage Ratio

RVMD's quarterly Leverage Ratio and Total Liabilities, Equity growth




RVMD Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change 6.77 % -27.18 % -23.75 % 26.94 % 26.36 %
Y / Y Total Liabilities Change 49.31 % 50.45 % 47.95 % 922.73 % 1149.48 %
Leverage Ratio MRQ 0.21 0.27 0.24 0.22 0.15
Overall Ranking # # # # #
Seq. Equity Change 36.6 % -9.47 % -8.56 % -5.58 % -6.83 %
Seq. Total Liabilities Change 7.86 % 1.65 % -2.69 % 39.94 % 8.68 %



Leverage Ratio third quarter 2022 Comment
In Spite of the net new borrowings of 7.86% Revolution Medicines Inc managed to improve Leverage Ratio in the third quarter 2022 to 0.21, above company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are RVMD Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Revolution Medicines Inc 's Equity $ 681 Millions Visit RVMD's Balance sheet
Revolution Medicines Inc 's Total Liabilities $ 144 Millions Visit RVMD's Balance sheet
Source of RVMD's Sales Visit RVMD's Sales by Geography


Cumulative Revolution Medicines Inc 's Leverage Ratio

RVMD's Leverage Ratio for the trailling 12 Months

RVMD Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth 6.77 % -27.18 % -23.75 % 26.94 % 26.36 %
Y / Y Total Liabilities TTM Growth 49.31 % 50.45 % 47.95 % 922.73 % 1149.48 %
Leverage Ratio TTM 0.23 0.22 0.18 0.15 0.11
Total Ranking TTM # 389 # 553 # 269 # 452 # 354
Seq. Equity TTM Growth 36.6 % -9.47 % -8.56 % -5.58 % -6.83 %
Seq. Total Liabilities TTM Growth 7.86 % 1.65 % -2.69 % 39.94 % 8.68 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 7.86%, Leverage Ratio improved to 0.23, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 54 other companies have achieved lower Leverage Ratio than Revolution Medicines Inc . While total ranking remained unchanged compare to previous quarter at no. 389.

Explain Leverage Ratio?
Who are RVMD Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 55
Healthcare Sector # 244
Within the Market # 389


TTM Leverage Ratio Statistics
High Average Low
0.23 0.18 0.15
(Sep 30 2022)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Recursion Pharmaceuticals Inc   0.58 $ 223.499  Millions$ 388.034  Millions
Eyepoint Pharmaceuticals Inc   0.57 $ 77.905  Millions$ 136.350  Millions
Regenxbio Inc   0.57 $ 319.969  Millions$ 563.824  Millions
Hydrofarm Holdings Group Inc   0.56 $ 214.769  Millions$ 382.505  Millions
Finch Therapeutics Group Inc   0.56 $ 67.102  Millions$ 120.866  Millions
Century Therapeutics inc   0.55 $ 181.546  Millions$ 330.205  Millions
Myomo Inc   0.53 $ 4.114  Millions$ 7.822  Millions
Bluebird Bio Inc   0.52 $ 83.028  Millions$ 158.857  Millions
Denali Therapeutics Inc   0.51 $ 416.303  Millions$ 811.303  Millions
Kodiak Sciences Inc   0.51 $ 244.459  Millions$ 479.529  Millions
Gritstone Bio Inc   0.50 $ 68.395  Millions$ 136.847  Millions
Berkeley Lights Inc   0.48 $ 76.701  Millions$ 158.183  Millions
Voyager Therapeutics Inc   0.48 $ 38.636  Millions$ 79.823  Millions
Immucell Corp  0.45 $ 14.419  Millions$ 31.983  Millions
C4 Therapeutics Inc   0.45 $ 143.260  Millions$ 318.179  Millions
Moderna Inc   0.45 $ 8,064.000  Millions$ 17,992.000  Millions
Vaxart Inc   0.43 $ 53.002  Millions$ 122.307  Millions
Alpha Teknova Inc   0.43 $ 48.276  Millions$ 111.996  Millions
Arcellx Inc   0.43 $ 101.043  Millions$ 236.284  Millions
Bio rad Laboratories Inc   0.42 $ 3,570.814  Millions$ 8,453.605  Millions
Cue Health Inc   0.40 $ 235.076  Millions$ 589.960  Millions
Heska Corporation  0.40 $ 162.168  Millions$ 407.899  Millions
Vericel Corporation  0.39 $ 70.180  Millions$ 177.837  Millions
Avanos Medical Inc   0.39 $ 498.300  Millions$ 1,263.500  Millions
Edwards Lifesciences Corporation  0.39 $ 2,420.400  Millions$ 6,217.800  Millions
Neurocrine Biosciences Inc   0.39 $ 598.800  Millions$ 1,544.600  Millions
Surface Oncology Inc   0.39 $ 43.454  Millions$ 112.819  Millions
Vicarious Surgical Inc   0.38 $ 41.723  Millions$ 108.952  Millions
Tscan Therapeutics Inc   0.38 $ 43.970  Millions$ 116.658  Millions
Tcr2 Therapeutics Inc   0.37 $ 74.377  Millions$ 198.550  Millions

Date modified: 2022-11-08T18:12:02+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GNW's Profile

Stock Price

GNW's Financials

Business Description

Fundamentals

Charts & Quotes

GNW's News

Suppliers

GNW's Competitors

Customers & Markets

Economic Indicators

GNW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071